Mouse CD69 Antibody from BIOLEGEND
Search, find, compare suppliers for anti-Mouse CD69 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Mouse CD69 |
| Clone | H1.2F3 |
| Host Species | Armenian Hamster |
| Reactive Species | mouse |
| Isotype | IgG |
| Format | fluorescein (FITC) conjugate |
| Size | 500 µg |
| Concentration | n/a |
| Applications | Flow Cytometry (FC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | FITC anti-mouse CD69. CD69 is a 60 kD type II membrane protein composed of a 27/33 kD disulfide-linked homodimer, also known as Very Early Activation Antigen (VEA), AIM, EA1, MLR3, and gp34/28. It is expressed on a subset of thymocytes and platelets. CD69 is rapidly induced on activated T and B cells, neutrophils, and NK cells. It is a C-type lectin, closely related to the NKR-P1 and Ly-49 NK cell activation molecules. CD69 is involved in the early events of cell activation and thymocyte positive selection. |
| Immunogen | Mouse dendritic epidermal T cell line Y245 |
| Other Names | Very Early Activation Antigen (VEA), AIM, EA1, MLR3, gp34/28 |
| Gene, Accession # | Gene ID: 12515 |
| Catalog # | 104506 |
| Price | $293 |
| Order / More Info | Mouse CD69 Antibody from BIOLEGEND |
| Product Specific References | PubMed: 22253596, 22891353, 23261528, 24819296, 25505280, 25048196, 26436766, 26544979, 26769625, 26631269, 26831578, 26315532, 27186978, 27611574, 28771521, 29691463, 29848443, 29848443, 29316433, 29625895, 30327417, 31123687, 30811982, 30566865, 30566882, 31269441, 30889381, 30811982, 30566865, 29625895, 29316433, 29848443, 30566882, 30566881, 28709804, 30566881, 30925723, 31525249, 31913278, 31433988, 32157087, 31827233, 31940270, 32983109, 33159855, 33852868, 33979578 |
BIOLEGEND
BIOLEGEND
8999 BioLegend Way
San Diego CA 92121
P: (858) 455-9588
P: 1-877-Bio-Legend (246-5343)
F: (858) 455-9587
customerserv@biolegend.com
http://www.biolegend.com
Profile of BIOLEGEND
Return to Antibodies